SenzaGen is proud to sponsor, exhibit and present poster at the ESTIV conference, 2018.

The conference emphasis will be specifically on how new technologies can strengthen the interpretation and application of in vitro methods in toxicological research and risk assessment.

The ESTIV conference will be the official launch of the new GARDair, the first in vitro test for airway allergies.

Find us in Booth #19
Poster: GARDair – A novel assay for assessment of chemical respiratory sensitizers based on a genomic platform